Prof Dr. Seung Bum Park | Molecular Diversity | Best Researcher Award

Professor at Seoul National Universy, South Korea

Seung Bum Park is a renowned Professor and Director at the CRI Center for Chemical Proteomics in the Department of Chemistry at Seoul National University. His research focuses on chemical biology, drug discovery, and high-content phenotypic screening, utilizing diverse approaches to explore and manipulate biological systems. With a background in bioorganic chemistry, Park has made significant contributions to the understanding of molecular mechanisms and the development of innovative chemical tools for biomedical research.

Author Metrics

Scopus Profile

ORCID Profile

Google Scholar Profile

Seung Bum Park has a distinguished record of research output, with numerous publications in high-impact journals. His work is frequently cited, reflecting his influence in the fields of chemical biology and drug discovery. His author metrics, including citations and h-index, highlight his contributions to advancing scientific knowledge and his impact on the research community.

  • Citations: Park’s work has garnered 8,232 citations, illustrating the impact and relevance of his research within the scientific community.
  • Documents: He has published 168 documents, including research papers, reviews, and contributions to scientific literature.
  • h-index: With an h-index of 45, Park has a substantial number of publications that have been widely cited, indicating both the quality and quantity of his research output.

Education

Seung Bum Park completed his Ph.D. in Bioorganic Chemistry at Texas A&M University under the mentorship of Prof. Robert F. Standaert, where he was awarded the Boehringer-Ingelheim Fellowship. He holds an M.S. in Organic Chemistry and a B.S. in Chemistry, both from Yonsei University, where he graduated summa cum laude. His educational background underscores a strong foundation in both organic and bioorganic chemistry.

Research Focus

Park’s research interests are broad and interdisciplinary, encompassing chemical biology, diversity-oriented synthesis, drug discovery, and fluorescent bioimaging. His work aims to identify new drug targets and develop chemical probes to elucidate complex biological processes. His research integrates high-content phenotypic screening and target identification, striving to advance therapeutic development and understand disease mechanisms at a molecular level.

Professional Journey

Park’s professional journey includes notable positions across prestigious institutions. He currently serves as a Professor at Seoul National University, where he has held various academic roles since 2004. His experience also includes postdoctoral work at Harvard University as a Howard Hughes Medical Institute Fellow and a visiting professorship at The Scripps Research Institute. His career reflects a strong commitment to research excellence and academic leadership.

Honors & Awards

Seung Bum Park has received numerous honors and awards for his contributions to science and research. These include the Science and Technology Medal of Honor from the Korean Government, the Presidential Young Scientist Award, and several research excellence awards from Seoul National University and other institutions. His accolades recognize his innovative research and leadership in the scientific community.

Publications Noted & Contributions

Park has authored and co-authored over 195 research papers, with notable contributions to journals such as Cell, Angewandte Chemie, and ACS Chemical Biology. His work covers a range of topics from bioorthogonal chemistry to molecular degradation strategies, highlighting his expertise and impact in chemical biology. His publications are influential, contributing significantly to the advancement of scientific knowledge in his field.

1. Inflachromene Ameliorates Parkinson’s Disease by Targeting Nrf2-Binding Keap1

  • Journal: Chemical Science
  • Year: 2024
  • DOI: 10.1039/D3SC06997D
  • Contributors: Junhyeong Yim, Yoon Soo Hwang, Jae-Jin Lee, Ju Hee Kim, Jeong Yeob Baek, Jaeyeong Jeong, Young Il Choi, Byung Kwan Jin, Seung Bum Park
  • Summary: This paper explores how Inflachromene, a chemical compound, impacts Parkinson’s disease by targeting and modulating the Nrf2-binding protein Keap1. The study provides insights into potential therapeutic strategies for neurodegenerative diseases.

2. Unveiled Reactivity of Masked Diformylmethane with Enamines Forming Resonance-Assisted Hydrogen Bonding Leads to Di-Meta-Substituted Pyridines

  • Journal: Communications Chemistry
  • Year: 2024-06-28
  • DOI: 10.1038/s42004-024-01228-w
  • Contributors: Sihyeong Yi, Ji Hyae Lee, Hana Cho, Kannan Vaithegi, Dawon Yi, Sijun Noh, Seung Bum Park
  • Summary: The research details the reaction of masked diformylmethane with enamines, leading to the formation of di-meta-substituted pyridines. The study highlights the role of resonance-assisted hydrogen bonding in this chemical process.

3. Rational Design of Pyrido[3,2-b]indolizine as a Tunable Fluorescent Scaffold for Fluorogenic Bioimaging

  • Journal: JACS Au
  • Year: 2024-06-10
  • DOI: 10.1021/jacsau.4c00135
  • Contributors: Sihyeong Yi, Dahham Kim, Wansang Cho, Jung Ho Lee, Ji Hoon Kwon, Jonghoon Kim, Seung Bum Park
  • Summary: This publication presents the design of a pyrido[3,2-b]indolizine scaffold with tunable fluorescent properties for bioimaging applications. The study demonstrates the potential of this scaffold in developing advanced fluorescent probes.

4. Unveiling the Concealed Reactivity of Masked Diformylmethane with RAHB-Assisted Enamines Leads to Dissymmetric Di-Meta-Substituted Pyridines

  • Preprint: 2024-03-18
  • DOI: 10.21203/rs.3.rs-4020381/v1
  • Contributors: Seung Bum Park, Sihyeong Yi, Ji Hyae Lee, Hana Cho, Kannan Vaithegi, Dawon Yi, Sijun Noh
  • Summary: This preprint discusses the reaction mechanisms involving masked diformylmethane and resonance-assisted hydrogen bonding (RAHB) with enamines, leading to the formation of dissymmetric di-meta-substituted pyridines.

5. Ultrafluorogenic Monochromophore-Type BODIPY-Tetrazine Series for Dual-Color Bioorthogonal Imaging with a Single Probe

  • Journal: Angewandte Chemie
  • Year: 2023-12-21
  • DOI: 10.1002/ange.202316220
  • Contributors: Dahham Kim, Hayoung Son, Seung Bum Park
  • Summary: The article presents a series of ultrafluorogenic BODIPY-tetrazine probes designed for dual-color bioorthogonal imaging. The study demonstrates the utility of these probes in complex biological imaging applications.

Research Timeline

Over his career, Park has been involved in groundbreaking research projects and has made substantial contributions to his field. His research timeline includes pivotal studies on chemical probes, drug discovery, and phenotypic screening. Key milestones in his career include his tenure at Harvard, his leadership roles at Seoul National University, and his ongoing research in chemical proteomics.

Collaborations and Projects

Park’s research involves collaborations with leading institutions and researchers worldwide. His projects often include partnerships with organizations such as The Scripps Research Institute and the Genomic Institute of Novartis Foundation. His collaborative efforts extend to various international conferences and research initiatives, reflecting his active engagement in global scientific communities and projects.

Strengths of the Best Researcher Award

  1. Innovative Research Contributions
    • Prof. Dr. Seung Bum Park has made significant advancements in chemical biology and drug discovery, as demonstrated by his research on Inflachromene’s potential for treating Parkinson’s disease and his design of new fluorescent scaffolds for bioimaging. His work not only advances scientific understanding but also has practical applications in medicine.
  2. High Research Impact
    • With over 8,200 citations and an h-index of 45, Park’s research has had a profound impact on the scientific community. His high citation count reflects the relevance and influence of his work in chemical biology and drug discovery.
  3. Diverse Research Portfolio
    • Park’s research spans various fields, including chemical biology, drug discovery, and fluorescent bioimaging. This diverse portfolio highlights his ability to address complex scientific questions from multiple angles, showcasing his versatility and breadth of expertise.
  4. Academic Leadership and Recognition
    • As a professor and director at the CRI Center for Chemical Proteomics, Park has demonstrated leadership in both research and education. His numerous awards, including the Science and Technology Medal of Honor and the Presidential Young Scientist Award, underscore his recognition and respect within the scientific community.
  5. Strong Collaborative Network
    • Park’s collaborations with leading institutions such as Harvard University and The Scripps Research Institute exemplify his active engagement in the global scientific community. These partnerships enhance the scope and impact of his research, fostering innovation and knowledge exchange.

Areas for Improvement

  1. Broader Public Engagement
    • While Park’s research is highly specialized, increasing efforts to communicate scientific findings to the public could enhance the broader impact of his work. Engaging in outreach activities and public science communication could help bridge the gap between scientific research and societal benefit.
  2. Interdisciplinary Integration
    • Expanding research efforts to integrate more disciplines could further enhance the applicability of Park’s work. Collaborating with experts in fields such as computational biology, materials science, or environmental science might open new avenues for research and innovation.
  3. Focus on Translational Research
    • Although Park’s research has significant implications for drug discovery, emphasizing translational research—moving discoveries from the lab to clinical settings—could accelerate the development of new therapies and improve patient outcomes.
  4. Increased Focus on Emerging Technologies
    • Incorporating emerging technologies, such as artificial intelligence and machine learning, into research methodologies could enhance data analysis and interpretation. Adopting these technologies might provide new insights and streamline research processes.
  5. Expansion of Research Topics
    • Diversifying research topics to include emerging areas such as personalized medicine or regenerative medicine could broaden the impact of Park’s work. Exploring these cutting-edge fields could address new challenges and opportunities in biomedical research.

Conclusion

Prof. Dr. Seung Bum Park’s recognition as a Best Researcher highlights his outstanding contributions to chemical biology, drug discovery, and bioimaging. His innovative research, high impact, and leadership in the field underscore his prominence in the scientific community. While his achievements are impressive, there are opportunities to further enhance the reach and applicability of his work. By increasing public engagement, integrating interdisciplinary approaches, focusing on translational research, adopting emerging technologies, and expanding research topics, Park can continue to make significant strides in advancing scientific knowledge and addressing critical challenges in biomedical research.

Seung Bum Park | Molecular Diversity | Best Researcher Award